NO173081C - Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen - Google Patents

Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen

Info

Publication number
NO173081C
NO173081C NO865195A NO865195A NO173081C NO 173081 C NO173081 C NO 173081C NO 865195 A NO865195 A NO 865195A NO 865195 A NO865195 A NO 865195A NO 173081 C NO173081 C NO 173081C
Authority
NO
Norway
Prior art keywords
ibuprofen
preparing
procedure
tablets
coated
Prior art date
Application number
NO865195A
Other languages
English (en)
Norwegian (no)
Other versions
NO865195L (no
NO173081B (no
NO865195D0 (no
Inventor
Pyare Lal Seth
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of NO865195D0 publication Critical patent/NO865195D0/no
Publication of NO865195L publication Critical patent/NO865195L/no
Publication of NO173081B publication Critical patent/NO173081B/no
Publication of NO173081C publication Critical patent/NO173081C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Control Of El Displays (AREA)
  • Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO865195A 1986-06-25 1986-12-19 Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen NO173081C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2553/86A CH669523A5 (fi) 1986-06-25 1986-06-25

Publications (4)

Publication Number Publication Date
NO865195D0 NO865195D0 (no) 1986-12-19
NO865195L NO865195L (no) 1987-12-28
NO173081B NO173081B (no) 1993-07-19
NO173081C true NO173081C (no) 1993-10-27

Family

ID=4236387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865195A NO173081C (no) 1986-06-25 1986-12-19 Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen

Country Status (18)

Country Link
US (1) US4867987A (fi)
EP (1) EP0250648B1 (fi)
JP (1) JPS635020A (fi)
KR (1) KR930008956B1 (fi)
CN (1) CN1023191C (fi)
AT (1) ATE66370T1 (fi)
AU (1) AU590370B2 (fi)
CA (1) CA1276560C (fi)
CH (1) CH669523A5 (fi)
DE (1) DE3681031D1 (fi)
DK (1) DK616186A (fi)
ES (1) ES2029228T3 (fi)
FI (1) FI88580C (fi)
GR (1) GR3002579T3 (fi)
IL (1) IL81045A (fi)
NO (1) NO173081C (fi)
NZ (1) NZ218734A (fi)
ZA (1) ZA869586B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
WO2002043710A1 (fr) * 2000-11-28 2002-06-06 Irina Alekseevna Komissarova Composition pharmaceutique, son application et procede de fabrication
EP2422772A3 (en) * 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
BRPI0607110B1 (pt) * 2005-02-04 2016-06-28 Philip Morris Products Sa cigarro compreendendo um bastão de tabaco e um filtro multicomponente
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
WO2007069874A1 (en) * 2005-12-16 2007-06-21 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
KR101486228B1 (ko) 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
JP2010506833A (ja) * 2006-10-11 2010-03-04 アルファーマ，インコーポレイテッド 医薬組成物
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
JP5953646B2 (ja) * 2009-11-24 2016-07-20 大正製薬株式会社 イブプロフェン含有固形製剤
MX339408B (es) * 2010-03-09 2016-05-24 Alkermes Pharma Ireland Ltd Composiciones farmaceuticas entericas resistentes al alcohol.
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
JPS51127041A (en) * 1975-04-23 1976-11-05 Toyama Chem Co Ltd A process for preparing novel 2-( substituted phenyl) alkane acids and their salts.
US4447454A (en) * 1977-04-01 1984-05-08 The Upjohn Company Analgetic compounds, compositions and process of treatment
DE2908794C2 (de) * 1978-03-09 1984-09-13 Japan Atomic Energy Research Institute, Tokio/Tokyo Verfahren zur Herstellung eines eine physiologisch aktive Substanz enthaltenden Polymerpräparates
JPS6028809B2 (ja) * 1979-08-21 1985-07-06 日本原子力研究所 イブプロフエン徐放剤組成物の製造方法
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
CA1217429A (en) * 1982-07-22 1987-02-03 Eugene M. Laska Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances

Also Published As

Publication number Publication date
EP0250648B1 (de) 1991-08-21
IL81045A (en) 1990-11-05
ES2029228T3 (es) 1992-08-01
EP0250648A2 (de) 1988-01-07
FI865227A0 (fi) 1986-12-19
AU6680786A (en) 1988-01-07
DK616186A (da) 1987-12-26
KR930008956B1 (ko) 1993-09-17
CH669523A5 (fi) 1989-03-31
CN86108644A (zh) 1988-01-06
NO865195L (no) 1987-12-28
GR3002579T3 (en) 1993-01-25
US4867987A (en) 1989-09-19
EP0250648A3 (en) 1988-03-23
NO173081B (no) 1993-07-19
KR880000090A (ko) 1988-03-23
FI88580C (fi) 1993-06-10
DK616186D0 (da) 1986-12-19
NO865195D0 (no) 1986-12-19
IL81045A0 (en) 1987-03-31
CA1276560C (en) 1990-11-20
NZ218734A (en) 1990-03-27
JPS635020A (ja) 1988-01-11
DE3681031D1 (de) 1991-09-26
AU590370B2 (en) 1989-11-02
FI865227A (fi) 1987-12-26
ATE66370T1 (de) 1991-09-15
ZA869586B (en) 1988-07-27
CN1023191C (zh) 1993-12-22
FI88580B (fi) 1993-02-26

Similar Documents

Publication Publication Date Title
NO173081C (no) Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
AU4657085A (en) High density, delayed release lacquered pharmaceutical pellets
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
DK582287A (da) Middel til fremstilling af faste doseringsformer med ensartet og forsinket frigoerelse
GR3004448T3 (fi)
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
AU4927090A (en) Medicaments having controlled release of the active compound
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
EP0171528A3 (en) Controlled release pharmaceutical preparations
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
AU7095687A (en) Pellet-containing pharmaceutical compositions
DE3789258D1 (de) Multigranuläre Tablette mit verzögerter Freisetzung.
MY110206A (en) Substituted mandelic acid derivaties,processes for their preparation and their use in medicaments
GB1302266A (fi)
GB1378296A (en) Pharmaceutical composition